Picture of Nykode Therapeutics ASA logo

NYKD — Nykode Therapeutics ASA News Story

0.000.00%
no flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapMomentum Trap

Brief: Nykode Therapeutics Announces New Interim Data From Vb-C-03 Trial

Feb 24 (Reuters) - Nykode Therapeutics ASA NYKD.OL:

ANNOUNCES NEW INTERIM DATA FROM THE VB-C-03 TRIAL SHOWING ENCOURAGING ANTI-TUMOR ACTIVITY AND TOLERABILITY OF ABI-SUVA (VB10.16)

ANTI-TUMOR ACTIVITY OBSERVED WITH ORR OF 38.5%

Source text: ID:nObipvZrVa

Further company coverage: NYKD.OL

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Nykode Therapeutics ASA

See all news